Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Post by edroseon Jun 15, 2021 11:41am
90 Views
Post# 33388510

they sold plasma division just few weeks BEFORE FDA decisio

they sold plasma division just few weeks BEFORE FDA decisiodecision  and sold it for peanuts    plasma division as huge potential with ivig and ryplasim phase 3 studies with great results
in canda we use more ivig per person than any industrialized country   and they wrote down ivig for 150,000 milion in 2019 that was part of plan to wipe out retail investors 

then six month before they renegotiated  for 5 years but call in the loan  also nailing the nail in the coffin   letting them takeover the company    this will all be exposed in court and news paper not owned by thomson 

   


<< Previous
Bullboard Posts
Next >>